Guest blog: Patents in the biopesticide industry revealed

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Guest blog: Patents in the biopesticide industry revealed

Who is applying for patents in the biopesticide industry? Rubal Walia of INDUS TechInnovations explains

Although synthetic chemical fertilizers occupy a large share of pesticide market, biopesticides are gradually gaining significance. We have been looking at the patent landscape as well as the trends and patterns emerging in the Biopesticide industry.

We studied the patent filings in this technology area to understand the investments and patenting efforts being made. The infographic below outlines some interesting trends such as the pace of progress over the last decade, the geographical distribution of patents, patent transactions between different organisations and top patent asset holders.

The report displays a steady increase in published patents over the years, with 2012 revealing a sharp rise. Geographically, the US and China have dominated this area in patents and applications, followed by Europe. In addition, Monsanto, one of the pioneers in developing genetically modified seeds, leads the race as the top patent asset holder, with more than 1,400 patents. Pioneer, a Dupont company, is close behind with more than 1,000 patents.

The report also indicates that Monsanto is among the top acquirers of patents, buying patents from companies such as D&PL Technologies, Pharmacia, and Ecogen. Rivals Bayer and Gibraltar Business Capital have also acquired a large number of patents. You can see more information in the graphic.

Image The infographic was produced by Relecura, a patent and portfolio analysis platform developed by INDUS TechInnovations.

more from across site and SHARED ros bottom lb

More from across our site

King & Spalding has now hired 15 partners from Winston Taylor and legacy firm Winston & Strawn in offices spanning Texas, San Francisco, and Chicago
Firm says its work with a biotech client could signal a sea change in how - and when - law firms enter the drug development process
Evan Lazerowitz, attorney in Robinson + Cole’s bankruptcy and reorganisation group, offers key takeaways for IP interested parties in bankruptcy and insolvency proceedings
While the UK sees heavy IP rankings movement, Germany’s new tiered UPC table signals a shift from early adoption to market maturity
In an exclusive interview, Bernard Ledeboer reveals how a Consolid-backed group of firms wants to expand across Europe, invest in AI and centralise operations to compete at the top tier
Not all private equity firms are the same, so leaders at four externally backed IP firms came together to discuss the frameworks they followed and how they ensured a cultural fit
Top-tier German and Spanish firms are among the advisers on a Europe-wide copyright and licensing tussle concerning the design of the track circuit in Madrid
Partners Alex Wilson and Andreas Kramer say bigger law firm rivals don’t necessarily gain by having a wider jurisdictional reach
VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
Gift this article